Phil is the Head of Vigilance Operations within MHRA’s Safety & Surveillance function and has over eighteen years of experience working in pharmacovigilance. Prior to his current role Phil spent nine years leading and developing the Signal Management function, including systems, processes, and relevant aspects of Pharmacovigilance Legislation.
He is accountable for the operational delivery of the Patient Safety Monitoring team, including the Yellow Card Scheme and Signal Management across medicines, vaccines, devices, and defects.
Phil is responsible delivery of MHRA systems for COVID-19 vaccine surveillance and their integration into the healthcare system. For several years he has led international projects to develop and deliver tools for global pharmacovigilance, which are now being used for vaccine surveillance internationally.